FDA Approves Generic Twice-Yearly HIV Prevention Shot Lenacapavir

The U.S. Food and Drug Administration has approved a generic version of lenacapavir, the only twice-a-year injection for HIV prevention. This approval is a significant step toward making the drug more affordable and accessible in 120 low- and middle-income countries.

Originally published by gnews